82
46. German A, Suraiya S, Tenenbaum-Rakover Y, Koren I, Pillar G. Hochberg Ze. control of childhood congenital adrenal hyperplasia and sleep activity and quality with morning or evening
glucocorticoid therapy. J Clin Endocrinol Metab. 2008;93(12):4707–10.
47. Bonfig W, Dalla Pozza SB, Schmidt H, Pagel P, Knorr D, Schwarz HP. Hydrocortisone dosing
during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based
recommendation. J Clin Endocrinol Metab. 2009;94(10):3882–8.
48. El-Maouche D, Collier S, Prasad M, Reynolds JC, Merke DP.  Cortical bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin
Endocrinol. 2015;82(3):330–7.
49. Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, et al. Congenital adrenal
hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice
guideline. J Clin Endocrinol Metab. 2010;95(9):4133–60.
50. Bidet M, Bellanne-Chantelot C, Galand-Portier M-B, Golmard J-L, Tardy V, Morel Y, et al.
Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase
deficiency. J Clin Endocrinol Metab. 2010;95(3):1182–90.
51. Auchus RJ. Congenital adrenal hyperplasia in adults. Curr Opin Endocrinol Diabetes Obes.
2010;17(3):210–6.
52. Gomes LG, Huang N, Agrawal V, Mendonça BB, Bachega TA, Miller WL.  Extraadrenal
21-hydroxylation by CYP2C19 and CYP3A4: effect on 21-hydroxylase deficiency. J Clin
Endocrinol Metab. 2009;94(1):89–95.
M. Shahid et al.